Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.

CSF was analysed for neurofilament light protein, total tau, glial fibrillary acidic protein, S-100B and albumin concentrations. Serum was analysed for S-100B and albumin. Results: None of the ...